Xu Zhenyu 4
4 · SOPHiA GENETICS SA · Filed Apr 21, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CSO Xu Zhenyu Sells 608 Shares
What Happened Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA (SOPH), sold 608 shares in an open‑market transaction on April 20, 2026. The weighted average sale price was $5.21 per share, for total proceeds of approximately $3,165. This was a sale (not a purchase or option exercise).
Key Details
- Transaction date: April 20, 2026; Form 4 filed April 21, 2026 (timely).
- Transaction type/code: Sale (S).
- Price: weighted average $5.21; actual sale prices ranged from $5.10 to $5.29 (footnote F2).
- Total proceeds: ~$3,165.
- Shares owned after transaction: Not disclosed in this filing.
- Footnotes: F1 states the shares were sold to satisfy tax withholding from RSU vesting on April 18, 2026 and were sold under a pre‑established Rule 10b5‑1(c) plan (non‑discretionary). F2 notes the weighted average price and offers a breakdown of per‑price quantities upon request.
Context The sale was executed to cover tax withholding tied to restricted stock unit vesting and was made pursuant to a standing 10b5‑1 plan, which the filer says removes discretion from the timing of the trades. Such tax‑withholding sales are common and do not, by themselves, indicate the insider's view on the company's prospects.
Insider Transaction Report
Form 4
Xu Zhenyu
Chief Scientific Officer
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-04-20$5.21/sh−608$3,165→ 630,888 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Elimara Brunetto as Attorney-in-fact for Zhenyu Xu|2026-04-21